Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 743

1.

Controlling Molecular Doping in Organic Semiconductors.

Jacobs IE, Moulé AJ.

Adv Mater. 2017 Sep 15. doi: 10.1002/adma.201703063. [Epub ahead of print] Review.

PMID:
28921668
2.

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.

Rosen LS, Jacobs IA, Burkes RL.

Target Oncol. 2017 Aug 11. doi: 10.1007/s11523-017-0518-1. [Epub ahead of print] Review.

PMID:
28801849
3.

Self-reported transvaginal ultrasound visualization of normal ovaries in postmenopausal women is not reliable: results of expert review of archived images in UKCTOCS.

Stott W, Campbell S, Franchini A, Blyuss O, Zaikin A, Ryan A, Jones C, Gentry-Maharaj A, Fletcher G, Kalsi J, Skates S, Parmar M, Amso N, Jacobs I, Menon U.

Ultrasound Obstet Gynecol. 2017 Aug 10. doi: 10.1002/uog.18836. [Epub ahead of print]

PMID:
28796383
4.

Steady, relentless progress towards effective, safe screening for early detection of cancer of the ovary.

Jacobs I.

BJOG. 2017 Jul 28. doi: 10.1111/1471-0528.14830. [Epub ahead of print] No abstract available.

PMID:
28752542
5.

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Menon U, McGuire AJ, Raikou M, Ryan A, Davies SK, Burnell M, Gentry-Maharaj A, Kalsi JK, Singh N, Amso NN, Cruickshank D, Dobbs S, Godfrey K, Herod J, Leeson S, Mould T, Murdoch J, Oram D, Scott I, Seif MW, Williamson K, Woolas R, Fallowfield L, Campbell S, Skates SJ, Parmar M, Jacobs IJ.

Br J Cancer. 2017 Aug 22;117(5):619-627. doi: 10.1038/bjc.2017.222. Epub 2017 Jul 25.

6.

Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Xu C, Hermes DJ, Nwanguma B, Jacobs IR, Mackie K, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska B, Fitting S.

Mol Cell Neurosci. 2017 Sep;83:92-102. doi: 10.1016/j.mcn.2017.07.003. Epub 2017 Jul 19.

7.

Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.

Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ, Menon U, Jacobs I, Legood R.

Am J Obstet Gynecol. 2017 Jul 6. pii: S0002-9378(17)30842-6. doi: 10.1016/j.ajog.2017.06.038. [Epub ahead of print]

PMID:
28690137
8.

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.

Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, Ainley C, Whetton AD, Menon U, Jacobs I, Graham RLJ.

Br J Cancer. 2017 Aug 22;117(5):666-674. doi: 10.1038/bjc.2017.199. Epub 2017 Jun 29.

9.

Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis.

Simoens S, Jacobs I, Popovian R, Isakov L, Shane LG.

Pharmacoeconomics. 2017 Jun 28. doi: 10.1007/s40273-017-0529-x. [Epub ahead of print] Review.

PMID:
28660473
10.

Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Trembling PM, Apostolidou S, Gentry-Maharaj A, Parkes J, Ryan A, Tanwar S, Burnell M, Jacobs I, Menon U, Rosenberg WM.

BMC Public Health. 2017 Jun 28;17(1):603. doi: 10.1186/s12889-017-4518-y.

11.

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.

Yang WL, Gentry-Maharaj A, Simmons A, Ryan A, Fourkala EO, Lu Z, Baggerly KA, Zhao Y, Lu KH, Bowtell D, Jacobs I, Skates SJ, He WW, Menon U, Bast RC Jr; AOCS Study Group.

Clin Cancer Res. 2017 Jun 21. doi: 10.1158/1078-0432.CCR-17-0284. [Epub ahead of print]

PMID:
28637689
12.

Can biosimilars help achieve the goals of US health care reform?

Boccia R, Jacobs I, Popovian R, de Lima Lopes G Jr.

Cancer Manag Res. 2017 Jun 1;9:197-205. doi: 10.2147/CMAR.S133442. eCollection 2017. Review.

13.

Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape.

Subramanian J, Cavenagh J, Desai B, Jacobs I.

Cancer Manag Res. 2017 Apr 24;9:131-140. doi: 10.2147/CMAR.S120589. eCollection 2017. Review.

14.

Exercise Is Medicine, But Does It Interfere With Medicine?

McLaughlin M, Jacobs I.

Exerc Sport Sci Rev. 2017 Jul;45(3):127-135. doi: 10.1249/JES.0000000000000111.

PMID:
28418997
15.

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

Monk BJ, Huh WK, Rosenberg JA, Jacobs I.

Gynecol Oncol Res Pract. 2017 Mar 21;4:7. doi: 10.1186/s40661-017-0045-x. eCollection 2017. Review.

16.

Biosimilar biologic drugs: a new frontier in medical care.

Geynisman DM, De Velasco G, Sewell KL, Jacobs I.

Postgrad Med. 2017 May;129(4):460-470. doi: 10.1080/00325481.2017.1311196. Epub 2017 Apr 3. Review.

PMID:
28343424
17.

Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening.

Gentry-Maharaj A, Karpinskyj C, Glazer C, Burnell M, Bailey K, Apostolidou S, Ryan A, Lanceley A, Fraser L, Jacobs I, Hunter MS, Menon U.

Climacteric. 2017 Jun;20(3):240-247. doi: 10.1080/13697137.2017.1301919. Epub 2017 Mar 22.

18.

The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT.

Fallowfield L, Solis-Trapala I, Menon U, Langridge C, May S, Jacobs I, Jenkins V.

Br J Cancer. 2017 Apr 11;116(8):1111-1117. doi: 10.1038/bjc.2017.72. Epub 2017 Mar 21.

PMID:
28324886
19.

Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis.

PRISM Investigators, Rowan KM, Angus DC, Bailey M, Barnato AE, Bellomo R, Canter RR, Coats TJ, Delaney A, Gimbel E, Grieve RD, Harrison DA, Higgins AM, Howe B, Huang DT, Kellum JA, Mouncey PR, Music E, Peake SL, Pike F, Reade MC, Sadique MZ, Singer M, Yealy DM.

N Engl J Med. 2017 Jun 8;376(23):2223-2234. doi: 10.1056/NEJMoa1701380. Epub 2017 Mar 21.

PMID:
28320242
20.

Biosimilars: Considerations for Oncology Nurses
.

Vizgirda V, Jacobs I.

Clin J Oncol Nurs. 2017 Apr 1;21(2):E54-E60. doi: 10.1188/17.CJON.E54-E60.

PMID:
28315542

Supplemental Content

Loading ...
Support Center